REGN
NASDAQ NMS - GLOBAL MARKETUSRegeneron Pharmaceuticals Inc
Biotechnology
$803.48USD
▼ 2.49 (0.31%)
● Live
Key Metrics
Revenue TTM
$15.36B
Profit Margin
27.86%
EPS (TTM)
$40.45
52-Week High
$821.11
52-Week Low
$541.00
P/E Ratio
18.98
Forward P/E
14.12
ROE
13.81%
Debt / Equity
0.09×
Market Cap
$82.77B
Athena Intelligence
● AnalyzingAthena AI Model v1.0
Athena Intelligence
Analyzing REGN
Reading financial statements●
Evaluating profitability metrics
Scanning market sentiment
Analyzing valuation multiples
Building investment thesis
52-Week Range
$541.00
$821.11
52W LowCurrent: $803.48 (93.7% of range)52W High